The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Metabolic reprogramming and flux to cell envelope precursors in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibiotics
Abstract
Central metabolic pathways controls virulence and antibiotic resistance, and constitute potential targets for antibacterial drugs. In Staphylococcus aureus the role of the pentose phosphate pathway (PPP) remains largely unexplored. Mutation of the 6-phosphogluconolactonase gene pgl, which encodes the only non-essential enzyme in the oxidative phase of the PPP, significantly increased MRSA resistance to β-lactam antibiotics, particularly in chemically defined media with glucose, and reduced oxacillin (OX)-induced lysis. Expression of the methicillin-resistance penicillin binding protein 2a and peptidoglycan architecture were unaffected. Carbon tracing and metabolomics revealed extensive metabolic reprogramming in the pgl mutant including increased flux to glycolysis, the TCA cycle, and several cell envelope precursors, which was consistent with increased β-lactam resistance. Morphologically, pgl mutant cells were smaller than wild-type with a thicker cell wall and ruffled surface when grown in OX. Further evidence of the pleiotropic effect of the pgl mutation was reduced resistance to Congo Red, sulfamethoxazole and oxidative stress, and increased resistance to targocil, fosfomycin and vancomycin. Reduced binding of wheat germ agglutinin (WGA) to pgl was indicative of lower wall teichoic acid/lipoteichoic acid levels or altered teichoic acid structures. Mutations in the vraFG or graRS loci reversed the increased OX resistance phenotype and restored WGA binding to wild-type levels. VraFG/GraRS was previously implicated in susceptibility to cationic antimicrobial peptides and vancomycin, and these data reveal a broader role for this multienzyme membrane complex in the export of cell envelope precursors or modifying subunits required for resistance to diverse antimicrobial agents. Altogether our study highlights important roles for the PPP and VraFG/GraRS in β-lactam resistance, which will support efforts to identify new drug targets and reintroduce β-lactams in combination with adjuvants or other antibiotics for infections caused by MRSA and other β-lactam resistant pathogens. Author summary: High-level resistance to penicillin-type (β-lactam) antibiotics significantly limits the therapeutic options for patients with MRSA infections necessitating the use of newer agents, for which reduced susceptibility has already been described. Here we report for the first time that the central metabolism pentose phosphate pathway controls MRSA resistance to penicillin-type antibiotics. We comprehensively demonstrated that mutation of the PPP gene pgl perturbed metabolism in MRSA leading to increased flux to cell envelope precursors to drive increased antibiotic resistance. Moreover, increased resistance was dependent on the VraRG/GraRS multienzyme membrane complex previously implicated in resistance to antimicrobial peptides and vancomycin. Our data thus provide new insights on MRSA mechanisms of β-lactam resistance, which will support efforts to expand the treatment options for infections caused by this and other antimicrobial resistant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When glucose is abundant, S. aureus primarily uses glycolysis and the pentose phosphate pathway to generate ATP and biosynthetic precursors [137].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [137]
In the citing paper
“However, in glucose-limited conditions, the bacterium shifts to alternative carbon sources such as lactate, which is transported into the cell via the lactate permease and converted into pyruvate for further processing in the tricarboxylic acid (TCA) cycle [137].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potter, A. D., Butrico, C. E., Ford, C. A., Curry, J. M., Trenary, I. A., Tummarakota, S. S., Hendrix, A. S., Young, J. D., & Cassat, J. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922211117 · Cited by 73
Research works printed but not linked: 91
- 10.1093/jac/dkac028 · DOI
- 2015, The World Health Organization Global Action Plan for antimicrobial resistance, S Afr Med J, 105, 325, 10.7196/SAMJ.9644 · DOI · Paper page
- 10.1056/NEJM199808203390806 · DOI · Paper page
- 10.1128/CMR.10.3.505 · DOI · Paper page
- 10.1006/mpat.1999.0272 · DOI · Paper page
- 10.1053/jinf.2000.0657 · DOI
- 10.1016/S0966-842X(98)01400-0 · DOI · Paper page
- 10.1128/CMR.00134-14 · DOI · Paper page
- 10.1016/S1473-3099(05)70295-4 · DOI · Paper page
- 1999, Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells, Microbiol-Uk, 145, 3477, 10.1099/00221287-145-12-3477 · DOI · Paper page
- 10.1086/314762 · DOI
- 10.1093/infdis/144.3.237 · doi:10.1093/infdis/144.3.237
- 10.1046/j.1365-2958.1999.01353.x · DOI · Paper page
- 10.1136/bmj.2.4534.863 · DOI
- 10.1128/AAC.37.5.1144 · DOI · Paper page
- 10.1136/jcp.14.4.385 · DOI · Paper page
- 10.1093/nar/18.18.5548 · doi:10.1093/nar/18.18.5548
- 10.1007/BF02464891 · DOI
- 10.1016/0378-1119(90)90481-6 · DOI · Paper page
- 10.1073/pnas.191260798 · DOI · Paper page
- 10.1128/JB.183.22.6525-6531.2001 · DOI · Paper page
- 10.1128/AAC.02802-14 · DOI
- 10.1371/journal.ppat.1008672 · DOI
- 10.1371/journal.pone.0082814 · DOI
- 10.1146/annurev-biochem-060614-034516 · DOI · Paper page
- 10.1128/mBio.01000-13 · DOI
- Mikkelsen K , Sirisarn W , Alharbi O , Alharbi M , Liu H , Nohr-Meldgaard K , et al. The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate beta-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids. Int J Antimicrob Agents. 2021:106283. · DOI
- 10.1089/mdr.1996.2.277 · DOI
- 10.1128/JB.186.6.1705-1713.2004 · doi:10.1128/jb.186.6.1705-1713.2004
- 10.1128/AAC.02697-15 · doi:10.1128/aac.02697-15
- Thalso-Madsen I , Torrubia FR , Xu L , Petersen A , Jensen C , Frees D . The Sle1 Cell Wall Amidase Is Essential for beta-Lactam Resistance in Community-Acquired Methicillin-Resistant Staphylococcus aureus USA300. Antimicrob Agents Chemother. 2019;64(1). · DOI
- 2015, The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A, Antimicrob Agents Chemother, 60, 1656
- 10.1128/AAC.00049-08 · DOI · Paper page
- Karinou E , Schuster CF , Pazos M , Vollmer W , Grundling A . Inactivation of the Monofunctional Peptidoglycan Glycosyltransferase SgtB Allows Staphylococcus aureus To Survive in the Absence of Lipoteichoic Acid. J Bacteriol. 2019;201(1). · DOI
- 10.1021/bi4016742 · doi:10.1021/bi4016742
- 10.1111/j.1365-2958.2009.06648.x · DOI
- Halsey CR , Lei S , Wax JK , Lehman MK , Nuxoll AS , Steinke L , et al. Amino Acid Catabolism in Staphylococcus aureus and the Function of Carbon Catabolite Repression. mBio. 2017;8(1). · DOI · Paper page
- 2021, Accumulation of Succinyl Coenzyme A Perturbs the Methicillin-Resistant Staphylococcus aureus (MRSA) Succinylome and Is Associated with Increased Susceptibility to Beta-Lactam Antibiotics, mBio, 12, e0053021, 10.1128/mBio.00530-21 · DOI
- 10.1371/journal.ppat.1003033 · DOI
- 10.1371/journal.ppat.1002217 · DOI · Paper page
- 10.1128/MMBR.00005-09 · DOI · Paper page
- Harper L , Balasubramanian D , Ohneck EA , Sause WE , Chapman J , Mejia-Sosa B , et al. Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. mBio. 2018;9(1). · DOI
- Vitko NP , Grosser MR , Khatri D , Lance TR , Richardson AR . Expanded Glucose Import Capability Affords Staphylococcus aureus Optimized Glycolytic Flux during Infection. mBio. 2016;7(3). · DOI · Paper page
- Vitko NP , Spahich NA , Richardson AR . Glycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus . mBio. 2015;6(2). · DOI · Paper page
- 10.1128/IAI.00762-10 · DOI
- 10.1111/brv.12140 · DOI · Paper page
- 2019, Transketolase of Staphylococcus aureus in the Control of Master Regulators of Stress Response During Infection, J Infect Dis, 220, 1967, 10.1093/infdis/jiz404 · DOI
- Gardner SG , Marshall DD , Daum RS , Powers R , Somerville GA . Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility. Antimicrob Agents Chemother. 2018;62(1). · DOI
- Katayama Y , Azechi T , Miyazaki M , Takata T , Sekine M , Matsui H , et al. Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus . Antimicrob Agents Chemother. 2017;61(11). · doi:10.1128/aac.00452-17
- 10.1073/pnas.1904280116 · DOI
- 10.1038/s41467-019-08724-x · DOI
- Nolan AC , Zeden MS , Kviatkovski I , Campbell C , Urwin L , Corrigan RM , et al. Purine Nucleosides Interfere with c-di-AMP Levels and Act as Adjuvants To Re-Sensitize MRSA To beta-Lactam Antibiotics. mBio. 2022:e0247822. · DOI
- 10.1074/jbc.M117.818716 · DOI
- 2019, RelQ Mediates the Expression of beta-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus, Front Microbiol, 10, 339, 10.3389/fmicb.2019.00339 · DOI
- 10.1128/JB.01201-13 · DOI · Paper page
- 10.1128/mBio.00537-12 · DOI · Paper page
- 10.1128/IAI.01511-08 · doi:10.1128/iai.01511-08
- Salamaga B , Kong L , Pasquina-Lemonche L , Lafage L , von Und Zur Muhlen M, Gibson JF, et al. Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and the action of bactericidal antibiotics. Proc Natl Acad Sci U S A. 2021;118(44). · doi:10.1073/pnas.2106022118
- 10.1093/jac/15.suppl_A.15 · doi:10.1093/jac/15.suppl_a.15
- 10.1046/j.1365-2958.2003.03719.x · DOI · Paper page
- 1972, Glucose metabolism in 6 phosphogluconolactonase mutants of Escherichia coli, J Biol Chem, 247, 1904, 10.1016/S0021-9258(19)45556-7 · doi:10.1016/s0021-9258(19)45556-7
- 10.1093/infdis/jiw461 · DOI
- 10.1038/s12276-018-0116-z · DOI · Paper page
- 10.1021/cb100269f · DOI · Paper page
- Rajagopal M , Martin MJ , Santiago M , Lee W , Kos VN , Meredith T , et al. Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. mBio. 2016;7(4). · DOI
- 10.1074/jbc.274.13.8405 · DOI · Paper page
- 10.1021/jacs.7b11704 · DOI
- 10.1111/j.1365-2958.2007.05986.x · DOI · Paper page
- 10.1073/pnas.0702159104 · DOI · Paper page
- 10.1128/AAC.00209-07 · DOI · Paper page
- 10.1371/journal.ppat.0030102 · DOI · Paper page
- 10.1128/AAC.05054-11 · DOI · Paper page
- 10.1073/pnas.1209126109 · DOI · Paper page
- Hesser AR , Matano LM , Vickery CR , Wood BM , Santiago AG , Morris HG , et al. The length of lipoteichoic acid polymers controls Staphylococcus aureus cell size and envelope integrity. J Bacteriol. 2020;202(16). · DOI
- 10.1074/jbc.REV119.010155 · DOI
- 2020, Staphylococcus aureus cell growth and division are regulated by an amidase that trims peptides from uncrosslinked peptidoglycan, Nat Microbiol, 5, 291, 10.1038/s41564-019-0632-1 · DOI
- 10.1111/j.1574-6968.2000.tb08877.x · doi:10.1111/j.1574-6968.2000.tb08877.x
- Ernst CM , Kuhn S , Slavetinsky CJ , Krismer B , Heilbronner S , Gekeler C , et al. The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits. mBio. 2015;6(1). · DOI · Paper page
- Slavetinsky CJ , Hauser JN , Gekeler C , Slavetinsky J , Geyer A , Kraus A , et al. Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF. Elife. 2022;11. · DOI
- 10.1371/journal.ppat.1000660 · DOI · Paper page
- 10.3389/fmicb.2018.01086 · DOI
- 10.1073/pnas.2123268119 · DOI
- 10.1111/mmi.12637 · DOI
- 10.1371/journal.pone.0021323 · DOI · Paper page
- 10.1016/0378-1119(91)90399-V · DOI · Paper page
- CLSI, 2018, Approved standard, 12th ed. CLSI standard M02-A13, 3, 15
- CLSI, 2018, CLSI standard M07-A11, 3, 27
- 10.1074/jbc.M116.747709 · DOI
- Fingleton C , Zeden MS , Bueno E , Cava F , O’Gara JP. Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to β-lactam antibiotics. bioRxiv. 2021:2021.02.03.429649. · doi:10.1101/2021.02.03.429649
- 10.1007/978-1-4939-3676-2_2 · DOI
- 10.1111/mmi.12266 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Zeden, M. S., Gallagher, L. A., Bueno, E., Nolan, A. C., Ahn, J., Shinde, D., Razvi, F., Sladek, M., Burke, Ó., O’Neill, E., Fey, P. D., Cava, F., Thomas, V. C., & O’Gara, J. P.
- Publisher
- openRxiv
- Published
- 2023-03-08
- Cited by
- 4
- References
- 1
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic reprogramming and flux to cell envelope precursors in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibiotics. https://app.cochat.ai/papers/10.1101/2023.03.03.530734
- The paper
- Zeden, M. S., Gallagher, L. A., Bueno, E., Nolan, A. C., Ahn, J., Shinde, D., Razvi, F., Sladek, M., Burke, Ó., O’Neill, E., Fey, P. D., Cava, F., Thomas, V. C., & O’Gara, J. P. (2023). Metabolic reprogramming and flux to cell envelope precursors in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibiotics. https://doi.org/10.1101/2023.03.03.530734
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.